U.S. House Passes Bill Criminalizing Gender Transition Procedures for Minors; Federal Employees File Complaint Over New Policy

The Republican-controlled U.S. House of Representatives passed legislation with a vote of 216 to 211, largely along party lines, that would make gender transition medical procedures for minors illegal. This includes surgeries, hormones, and puberty blockers. The bill proposes federal prison sentences of up to ten years for providers who offer or perform such treatments for individuals under 18.

Republican Representative Marjorie Taylor Greene of Georgia strongly pushed for this measure. She had previously made her support for a defense policy bill conditional on Speaker Mike Johnson bringing her legislation to a vote. Greene stated that the bill fulfills a key campaign promise by President Donald Trump and formalizes an executive order aimed at prohibiting gender-affirming medical interventions for minors. During the debate on the House floor, Greene displayed a poster of a child who had undergone such a procedure, arguing that “most Americans agree that kids just need to grow up before they do anything radical.”

It is considered unlikely that the legislation will advance in the Senate, where it would need bipartisan support to overcome procedural obstacles. Civil rights organizations have called the bill one of the most extreme anti-transgender measures ever considered by Congress. The vote reflects the priorities of the ultraconservative Republican majority and the Trump administration’s focus on restricting gender-related healthcare for minors.

Separately, the Trump administration is facing a formal legal complaint from federal employees affected by a new policy scheduled to take effect on Thursday. The Office of Personnel Management announced in August that health insurance plans for federal employees and U.S. Postal Service employees will no longer cover “chemical and surgical modification of an individual’s sex traits through medical interventions.” The Human Rights Campaign filed the grievance with the Equal Employment Opportunity Commission on Thursday, arguing that denying coverage constitutes sex-based discrimination.

The complaint, filed on behalf of four current federal workers at the State Department, Department of Health and Human Services, and Postal Service, includes statements from employees directly affected. One Postal Service employee described a daughter diagnosed with gender dysphoria whose doctors have recommended puberty blockers and possible hormone replacement therapy, treatments that would no longer be covered. The filing asserts the claim on behalf of these employees and a proposed class of similarly situated federal workers.

Human Rights Campaign Foundation President Kelley Robinson stated that the policy “is not about cost or care—it is about driving transgender people and people with transgender spouses, children, and dependents out of the federal workforce.”

This grievance comes amidst broader Trump administration efforts to limit access to gender-transition care, especially for minors. In December, the Department of Health and Human Services proposed rules that would prohibit such care for minors and deny Medicare and Medicaid funding to hospitals and providers offering these services to children. High-ranking officials, including HHS Secretary Robert F. Kennedy Jr., have described gender-affirming care for minors as “malpractice.” These positions contradict the recommendations of major medical organizations such as the American Medical Association and the American Academy of Pediatrics.

These developments illustrate ongoing tensions between the Trump administration’s policy objectives and advocacy groups seeking to maintain access to gender-related healthcare. While the House bill advances one element of the president’s agenda through legislative action, the OPM policy change represents an executive-branch initiative already facing a legal challenge. The complaint seeks the revocation of the coverage exclusion, setting the stage for potential administrative or judicial review.

Representative Greene, who was instrumental in securing the House vote, announced last month that she would leave Congress one year before her term ends. Her departure adds another layer of transition within the Republican conference as it pursues its legislative priorities.